You are here

breast cancer

Pfizer Unit Hid Menopause Drug's Risk of Breast Cancer, Lawyer Tells Jury

Bloomberg

Mon, 10/4/10 - 05:25 pm

Immunogen's T-DM1 Gets Presidential Treatment

Seeking Alpha

Sun, 10/3/10 - 11:48 am

Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breast Cancer Patients

Yahoo/BusinessWire

Sat, 10/2/10 - 11:20 am

Array Biopharma

Celsion Presents ThermoDox® Clinical Data at the 2010 Breast Cancer Symposium

Fri, 10/1/10 - 08:01 am

Dignity Medical

Amgen Drug May Block Some Breast Cancer, Studies Hint

Bloomberg

Thu, 09/30/10 - 11:24 am

BCA’s Brenner: Avastin And FDA Approval Standards

Pharmalot

Tue, 09/14/10 - 10:14 am

Pennsylvania Court Reinstates Pfizer HRT Lawsuits

Pharmalot

Wed, 09/1/10 - 06:39 pm

Immunogen: What Really Happened With T-DM1’s Filing?

Seeking Alpha

Wed, 09/1/10 - 08:08 am

FDA considers revoking approval of Avastin for advanced breast cancer

Washington Post, DC

Mon, 08/16/10 - 10:10 am

Avastin Breast Cancer Vote Signals Tough Environment For Drug Companies

Forbes

Wed, 07/21/10 - 07:59 am

targeted therapeutics

Roche's Avastin Not as Good in New Studies as Early Data Showed, FDA Says

Bloomberg

Fri, 07/16/10 - 08:23 am

Radiation Device Allows For Targeted Breast Radiation To Control Cancer

Tue, 07/13/10 - 09:35 am

Genentech's New Option for Breast Cancer Patients

Seeking Alpha

Sun, 07/11/10 - 02:31 pm

Trastuzumab-Dm1

Dune Medical Devices Announces Positive Interim Results From EU MarginProbe™ Study Presented at German Breast Cancer Society Meeting

Fri, 07/9/10 - 01:56 pm

Dune Medical Devices

Roche submits breast cancer drug for FDA approval

Reuters

Wed, 07/7/10 - 08:59 am

Trastuzumab-Dm1

There's A Lot To Like About Teva

Forbes

Thu, 07/1/10 - 08:45 am

Teva Pharmaceuticals

antidepressants

Dr. Reddy's Laboratories sells generic Arimidex

Yahoo/AP

Tue, 06/29/10 - 03:54 pm

Court Allows New Trial in Hormone Therapy Case

NY Times, NY

Mon, 06/21/10 - 12:04 pm

Neoprobe partners with Ohio organizations to market cancer drug

Sat, 06/19/10 - 11:23 am

radiopharmaceuticals

Phase III Study Results Showed Eisai’s Eribulin Mesylate Significantly Improved Overall Survival in Patients with Locally Recurrent or Metastatic Breast Cancer

BusinessWire

Sun, 06/6/10 - 12:31 pm

Eribulin Mesylate

Pages